Title |
Patient selection for corneal collagen cross-linking: an updated review
|
---|---|
Published in |
Clinical Ophthalmology, April 2017
|
DOI | 10.2147/opth.s101386 |
Pubmed ID | |
Authors |
Virgilio Galvis, Alejandro Tello, Alvaro I Ortiz, Luis C Escaf |
Abstract |
Corneal cross-linking (CXL) is an option that in the last decade has demonstrated its efficacy and safety in halting the progression of keratoconus (KCN) and other corneal ectasias. Its indication has been extended beyond the classic definition that required evidence of KCN progression, especially in the presence of some risk factors for a possible progression (particularly the younger age). However, the results can be still somewhat variable today. There are several protocols, each with its own advantages and disadvantages. Some predictors of CXL outcome have been identified. We will review the current knowledge on patient selection for CXL, its indications, and options in special cases (such as thin corneas). |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 85 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 12 | 14% |
Other | 8 | 9% |
Researcher | 7 | 8% |
Student > Doctoral Student | 7 | 8% |
Student > Master | 7 | 8% |
Other | 26 | 31% |
Unknown | 18 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 44 | 52% |
Biochemistry, Genetics and Molecular Biology | 6 | 7% |
Engineering | 4 | 5% |
Nursing and Health Professions | 3 | 4% |
Agricultural and Biological Sciences | 3 | 4% |
Other | 3 | 4% |
Unknown | 22 | 26% |